Demonstrações financeiras detalhadas de TG Therapeutics, Inc. (TGTX): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
TG Therapeutics, Inc. registou receitas de $616.3M no último exercício, com um CAGR de 5 anos de 426.7%.
Margens dos últimos 12 meses: margem bruta 82.4%, margem operacional 17.1%, margem líquida 55.2%.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $152381 | $152381 | $152000 | $152000 | $152000 | $6.7M | $2.8M | $233.7M | $329.0M | $616.3M |
| Custo da Receita | $62960 | $82355 | $88000 | 0 | 0 | $790000 | $265000 | $14.1M | $38.5M | $100.7M |
| Lucro Bruto | $89421 | $70026 | $64000 | $152000 | $152000 | $5.9M | $2.5M | $219.5M | $290.5M | $515.6M |
| P&D | $66.5M | $96.9M | $153.8M | $154.2M | $165.9M | $222.6M | $125.4M | $76.2M | $94.3M | $160.2M |
| Despesas Gerais e Administrativas | $9.9M | $16.3M | $15.2M | $15.0M | $107.8M | $128.1M | $95.5M | $122.7M | $154.3M | $232.0M |
| Despesas Operacionais | $79.1M | $118.9M | $174.6M | $169.2M | $273.7M | $350.7M | $220.8M | $198.9M | $248.6M | $392.2M |
| Lucro Operacional | -$79.0M | -$118.7M | -$174.4M | -$169.1M | -$273.6M | -$344.8M | -$218.3M | $20.6M | $41.9M | $123.3M |
| EBITDA | -$78.9M | -$118.4M | -$173.4M | -$167.3M | -$272.7M | -$342.0M | -$213.1M | $26.1M | $49.9M | $134.4M |
| Despesas com Juros | 0 | $1.1M | $1.7M | $5.3M | $6.3M | $5.6M | $10.2M | $12.6M | $24.0M | $26.7M |
| Lucro Antes de Impostos | -$78.3M | -$118.5M | -$173.5M | -$172.9M | -$279.4M | -$348.1M | -$223.8M | $13.1M | $25.6M | $107.4M |
| Imposto | -$716234 | -$235739 | -$918000 | 0 | 0 | 0 | 0 | $390000 | $2.2M | -$339.8M |
| Lucro Líquido | -$78.3M | -$118.5M | -$173.5M | -$172.9M | -$279.4M | -$348.1M | -$223.8M | $12.7M | $23.4M | $447.2M |
| LPA | $-1.60 | $-1.91 | $-2.30 | $-1.96 | $-2.42 | $-2.63 | $-1.46 | $0.09 | $0.16 | $3.10 |
| LPA Diluído | $-1.60 | $-1.91 | $-2.30 | $-1.96 | $-2.42 | $-2.63 | $-1.46 | $0.09 | $0.15 | $2.77 |
| Ações em Circulação (Diluídas) | $49.0M | $62.1M | $75.5M | $88.4M | $115.3M | $132.2M | $135.4M | $148.5M | $160.3M | $161.4M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $161.7M | $192.6M | $204.9M | $240.3M |
| Lucro Bruto | $133.6M | $154.4M | $171.4M | $199.1M |
| Lucro Operacional | $29.4M | $50.5M | $34.8M | $21.7M |
| EBITDA | $32.7M | $51.7M | $28.1M | $21.7M |
| Lucro Líquido | $390.9M | $23.0M | $19.8M | $7.8M |
| LPA | $2.69 | $0.16 | $0.14 | $0.05 |
| LPA Diluído | $2.43 | $0.14 | $0.12 | $0.05 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $25.0M | $56.7M | $42.0M | $112.6M | $553.4M | $298.9M | $102.3M | $92.9M | $179.9M | $79.1M |
| Investimentos de Curto Prazo | $19.9M | $28.0M | $26.8M | $27.8M | $52.0M | $15.9M | $59.4M | $124.6M | $131.1M | $62.8M |
| Contas a Receber | $83852 | $108468 | $95000 | 0 | 0 | $1.4M | 0 | $51.1M | $129.2M | $305.6M |
| Estoque | $5.6M | $7.9M | $9.7M | 0 | 0 | 0 | 0 | $39.8M | $110.5M | $125.6M |
| Ativos Circulantes | $50.9M | $93.3M | $79.0M | $149.2M | $611.7M | $331.0M | $168.3M | $317.9M | $566.4M | $630.8M |
| Imobilizado | $2.4M | $2.7M | $2.5M | $11.8M | $11.8M | $11.1M | $10.8M | $8.1M | $7.2M | $6.3M |
| Ágio | $799391 | $799391 | $799000 | $799000 | $799000 | $799000 | $799000 | $799000 | 0 | 0 |
| Ativos Intangíveis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Totais | $54.8M | $97.4M | $83.6M | $163.0M | $625.6M | $379.6M | $193.6M | $329.6M | $577.7M | $1.06B |
| Contas a Pagar | $15.3M | $25.9M | $36.4M | 0 | 0 | 0 | 0 | 0 | 0 | $107.5M |
| Dívida de Curto Prazo | $68875 | $127614 | $67000 | 0 | $22.2M | $975000 | 0 | 0 | 0 | $1.0M |
| Passivos Circulantes | $16.9M | $28.0M | $38.9M | $84.4M | $87.6M | $65.4M | $53.2M | $53.7M | $90.7M | $153.8M |
| Dívida de Longo Prazo | 0 | 0 | 0 | $29.0M | $7.7M | $66.8M | $71.1M | $100.1M | $244.4M | $252.7M |
| Passivos Totais | $54.8M | $97.4M | $59.6M | $124.4M | $106.3M | $142.5M | $135.0M | $169.1M | $355.3M | $415.2M |
| Reservas | -$236.4M | -$354.9M | -$528.3M | -$701.2M | -$980.6M | -$1.33B | -$1.53B | -$1.55B | -$1.53B | -$1.08B |
| Patrimônio Líquido | $35.9M | $67.0M | $24.0M | $38.6M | $519.4M | $237.2M | $58.6M | $160.5M | $222.4M | $648.0M |
| Dívida Total | $68875 | $127614 | $67000 | $40.8M | $42.0M | $79.0M | $83.1M | $110.8M | $253.7M | $260.7M |
| Dívida Líquida | -$44.9M | -$84.7M | -$68.7M | -$99.6M | -$563.5M | -$235.7M | -$78.6M | -$106.7M | -$57.3M | $118.8M |
| Capital de Giro | $34.0M | $65.4M | $40.2M | $64.7M | $524.2M | $265.6M | $115.1M | $264.2M | $475.7M | $477.0M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $74.1M | $79.1M | $442.2M | $482.6M |
| Ativos Totais | $1.03B | $1.06B | $1.53B | $1.64B |
| Passivos Totais | $417.8M | $415.2M | $945.7M | $1.04B |
| Patrimônio Líquido | $607.2M | $648.0M | $583.1M | $604.1M |
| Dívida Total | $253.7M | $260.7M | $753.6M | $754.4M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | -$78.3M | -$118.5M | -$173.5M | -$172.9M | -$279.4M | -$348.1M | -$198.3M | $12.7M | $23.4M | $447.2M |
| Depreciação e Amortização | $62960 | $82355 | $88000 | $282000 | $374000 | $494000 | $515000 | $423000 | $280000 | $59000 |
| Compensação em Ações | $7.5M | $15.9M | $12.9M | $11.3M | $80.3M | $61.3M | $19.2M | $37.9M | $42.5M | $64.7M |
| Variação Capital de Giro | $8.8M | $8.6M | $27.8M | $25.2M | -$19.8M | -$12.2M | -$1.6M | -$84.7M | -$109.3M | -$194.5M |
| Fluxo de Caixa Operacional | -$61.6M | -$93.8M | -$128.9M | -$132.8M | -$214.5M | -$295.6M | -$176.2M | -$31.4M | -$40.5M | -$24.8M |
| CapEx | -$343985 | -$2227 | -$90000 | -$131000 | -$357000 | -$401000 | -$14000 | 0 | -$45000 | -$214000 |
| Aquisições | 0 | 0 | 0 | $587000 | $24.2M | -$69000 | $20.0M | 0 | 0 | 0 |
| Recompra de Ações | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$8.8M | -$91.2M |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$61.9M | -$93.8M | -$129.0M | -$132.9M | -$214.9M | -$296.0M | -$176.2M | -$31.4M | -$40.6M | -$25.0M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | -$23.2M | $19.7M | -$17.9M | $21.4M |
| CapEx | -$80000 | -$67000 | -$51000 | -$344000 |
| Fluxo de Caixa Livre | -$23.2M | $19.6M | -$17.9M | $21.0M |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | $17.7M | $15.7M | $19.9M | $47.8M |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | +0.0% | -0.3% | +0.0% | +0.0% | +4300.7% | -58.4% | +8290.0% | +40.8% | +87.3% |
| Crescimento Lucro Líquido (anual) | | -51.4% | -46.4% | +0.4% | -61.6% | -24.6% | +35.7% | +105.7% | +84.5% | +1812.4% |
| Crescimento LPA (anual) | | -19.4% | -20.4% | +14.8% | -23.5% | -8.7% | +44.5% | +106.1% | +79.2% | +1837.5% |
| Variação de Ações (anual) | | +26.6% | +21.6% | +17.1% | +30.5% | +14.6% | +2.4% | +9.7% | +8.0% | +0.7% |
| Crescimento FCF (anual) | | -51.4% | -37.6% | -3.0% | -61.6% | -37.8% | +40.5% | +82.2% | -29.1% | +38.4% |
| Margem Bruta | 58.7% | 46.0% | 42.1% | 100.0% | 100.0% | 88.2% | 90.5% | 94.0% | 88.3% | 83.7% |
| Margem Operacional | -51823.5% | -77904.6% | -114736.8% | -111220.4% | -179996.1% | -5154.3% | -7839.0% | 8.8% | 12.7% | 20.0% |
| Margem EBITDA | -51782.0% | -77695.8% | -114075.0% | -110067.1% | -179393.4% | -5112.4% | -7651.9% | 11.2% | 15.2% | 21.8% |
| Margem Líquida | -51353.4% | -77749.9% | -114132.9% | -113730.9% | -183803.3% | -5204.1% | -8036.3% | 5.4% | 7.1% | 72.6% |
| Margem FCF | -40645.0% | -61533.8% | -84878.3% | -87458.6% | -141357.9% | -4425.7% | -6326.2% | -13.4% | -12.3% | -4.1% |
| Taxa Efetiva de Imposto | 0.9% | 0.2% | 0.5% | -0.0% | -0.0% | -0.0% | -0.0% | 3.0% | 8.6% | -316.4% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $-1.26 | $-1.51 | $-1.71 | $-1.50 | $-1.86 | $-2.24 | $-1.30 | $-0.21 | $-0.25 | $-0.15 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $49.0M | $62.1M | $75.5M | $88.4M | $115.3M | $132.2M | $135.4M | $142.0M | $145.3M | $144.3M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Margem bruta | 82.36% |
| Margem operacional | 17.05% |
| Margem líquida | 55.22% |
Saúde financeira
| Dívida / Patrimônio | 1.25 |
| Liquidez corrente | 4.27 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | -2.91 | -4.29 | -1.78 | -5.66 | -21.50 | -7.22 | -8.10 | 191.27 | 188.12 | 9.62 |
| P/VP | 6.36 | 7.60 | 12.87 | 25.40 | 11.55 | 10.59 | 27.34 | 15.11 | 19.67 | 6.64 |
| P/V | 1496.53 | 3340.12 | 2035.62 | 6453.25 | 39471.44 | 375.58 | 575.19 | 10.38 | 13.29 | 6.98 |
| Margem Bruta | 58.7% | 46.0% | 42.1% | 100.0% | 100.0% | 88.2% | 90.5% | 94.0% | 88.3% | 83.7% |
| Margem Operacional | -51823.5% | -77904.6% | -114736.8% | -111220.4% | -179996.1% | -5154.3% | -7839.0% | 8.8% | 12.7% | 20.0% |
| Margem Líquida | -51353.4% | -77749.9% | -114132.9% | -113730.9% | -183803.3% | -5204.1% | -8036.3% | 5.4% | 7.1% | 72.6% |